These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38047445)

  • 61. QSAR treatment of multiple toxicities: the mutagenicity and cytotoxicity of quinolines.
    Smith CJ; Hansch C; Morton MJ
    Mutat Res; 1997 Oct; 379(2):167-75. PubMed ID: 9357545
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of the computer programs DEREK and TOPKAT to predict bacterial mutagenicity. Deductive Estimate of Risk from Existing Knowledge. Toxicity Prediction by Komputer Assisted Technology.
    Cariello NF; Wilson JD; Britt BH; Wedd DJ; Burlinson B; Gombar V
    Mutagenesis; 2002 Jul; 17(4):321-9. PubMed ID: 12110629
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interpretation of nonlinear QSAR models applied to Ames mutagenicity data.
    Carlsson L; Helgee EA; Boyer S
    J Chem Inf Model; 2009 Nov; 49(11):2551-8. PubMed ID: 19824682
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mechanistic Reactivity Descriptors for the Prediction of Ames Mutagenicity of Primary Aromatic Amines.
    Kuhnke L; Ter Laak A; Göller AH
    J Chem Inf Model; 2019 Feb; 59(2):668-672. PubMed ID: 30694664
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterization and validation of an in silico toxicology model to predict the mutagenic potential of drug impurities.
    Valerio LG; Cross KP
    Toxicol Appl Pharmacol; 2012 May; 260(3):209-21. PubMed ID: 22426359
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A QSAR model for predicting mutagenicity of nitronaphthalenes and methylnitronaphthalenes.
    Zhang Z; Niu J; Zhi X
    Bull Environ Contam Toxicol; 2008 Nov; 81(5):498-502. PubMed ID: 18777149
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identification of the structural requirements for mutagencitiy, by incorporating molecular flexibility and metabolic activation of chemicals. II. General Ames mutagenicity model.
    Serafimova R; Todorov M; Pavlov T; Kotov S; Jacob E; Aptula A; Mekenyan O
    Chem Res Toxicol; 2007 Apr; 20(4):662-76. PubMed ID: 17381132
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Density Functional Theory Transition-State Modeling for the Prediction of Ames Mutagenicity in 1,4 Michael Acceptors.
    Townsend PA; Grayson MN
    J Chem Inf Model; 2019 Dec; 59(12):5099-5103. PubMed ID: 31774671
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Quantitative structure-mutagenic activity relationships of triazino indole derivatives.
    García E; Lopez-de-Cerain A; Martinez-Merino V; Monge A
    Mutat Res; 1992 Jul; 268(1):1-9. PubMed ID: 1378175
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mechanistic Task Groupings Enhance Multitask Deep Learning of Strain-Specific Ames Mutagenicity.
    Lui R; Guan D; Matthews S
    Chem Res Toxicol; 2023 Aug; 36(8):1248-1254. PubMed ID: 37478285
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Integrated in silico and in vitro genotoxicity assessment of thirteen data-poor substances.
    Tran YK; Buick JK; Keir JLA; Williams A; Swartz CD; Recio L; White PA; Lambert IB; Yauk CL
    Regul Toxicol Pharmacol; 2019 Oct; 107():104427. PubMed ID: 31336127
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mini mutagenicity test: a miniaturized version of the Ames test used in a prescreening assay for point mutagenesis assessment.
    Flamand N; Meunier J; Meunier P; Agapakis-Caussé C
    Toxicol In Vitro; 2001 Apr; 15(2):105-14. PubMed ID: 11287170
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The fungal metabolite culmorin and related compounds.
    Pedersen PB; Miller JD
    Nat Toxins; 1999; 7(6):305-9. PubMed ID: 11122521
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Approaches for externally validated QSAR modelling of Nitrated Polycyclic Aromatic Hydrocarbon mutagenicity.
    Gramatica P; Pilutti P; Papa E
    SAR QSAR Environ Res; 2007; 18(1-2):169-78. PubMed ID: 17365967
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prediction of mutagenicity and carcinogenicity using in silico modelling: A case study of polychlorinated biphenyls.
    Vračko M; Bobst S
    SAR QSAR Environ Res; 2015; 26(7-9):667-82. PubMed ID: 26329919
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A perspective on the development of the Ames Salmonella/mammalian-microsome mutagenicity assay.
    Mortelmans K
    Mutat Res Genet Toxicol Environ Mutagen; 2019 May; 841():14-16. PubMed ID: 31138405
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prediction of PAH mutagenicity in human cells by QSAR classification.
    Papa E; Pilutti P; Gramatica P
    SAR QSAR Environ Res; 2008; 19(1-2):115-27. PubMed ID: 18311639
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mutagenicity assessment strategy for pharmaceutical intermediates to aid limit setting for occupational exposure.
    Araya S; Lovsin-Barle E; Glowienke S
    Regul Toxicol Pharmacol; 2015 Nov; 73(2):515-20. PubMed ID: 26454093
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Relationships between chemical structures and mutagenicity: a preliminary survey for a database of mutagenicity test results of new work place chemicals.
    Sawatari K; Nakanishi Y; Matsushima T
    Ind Health; 2001 Oct; 39(4):341-5. PubMed ID: 11758998
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Quantitative structure-activity relationships for predicting mutagenicity and carcinogenicity.
    Patlewicz G; Rodford R; Walker JD
    Environ Toxicol Chem; 2003 Aug; 22(8):1885-93. PubMed ID: 12924587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.